The Cell Signaling in Cancer Conference: From Mechanisms to Therapy

May 15–19, 2022

Summary

May 15-19, 2022

Launched in 2016, this FASEB Science Research Conference (SRC) is a continuation of the successful FASEB SRC series Lipid Signaling Pathways in Cancer and its subsequent iterations from 2016 to 2020.

This year’s meeting is focused on genetic, molecular, and biochemical mechanisms underlying post- translational modifications that are often aberrant in cancer and proof-of-concept or clinically tractable means to translate these discoveries.

The program aims to disseminate and synthesize the most up-to-date knowledge and newest technologies surrounding mechanisms and therapeutic targeting of cancer cell signaling pathways.

It exposes basic/translational scientists and clinicians to the emerging concepts in the cancer cell signaling field and enhances cross-disciplinary interactions between academia, industry, and clinical science.

An important conference goal is to invest intellectually and financially in the future of the profession by supporting promising young trainees.

Program

The conference's main themes are: 1) Highlight the current advances in translating discoveries from the bench to the clinic; 2) Disseminate knowledge at the intersection of nutrient metabolism and cancer signaling pathways; 3) Present cutting-edge methodologies from chemical, structural, and systems biology to monitor cancer cell signaling dynamics; 4) Discuss the latest findings in signaling microdomains that influence therapeutic targeting; 5) Review the successes and controversies associated with targeting tumor microenvironmental signaling; 6) Support and encourage trainees to be successful and stay in the field of signal transduction as it specifically relates to cancer in order to exert a sustained and powerful impact on the field.

Conference sessions will present the latest research and foster discussion on:
  • Chemical Biology of Cancer Signaling
  • Signaling Microdomains in Cancer
  • Structure and Function of Cancer Signaling Complexes
  • Targeted Cancer Therapies at the Bench and In the Clinic
  • Systems Biology and Proteomics Approaches in Cancer
  • Nutrient Signaling in Cancer
  • Tumor Microenvironmental Signaling
  • RAS: The Past and The Future
  • Metabolite and Metabolic Processes in Cancer Signaling

The conference comprises one keynote lecture, 42 plenary lectures, up to 12 short talks from trainees and two poster sessions. It also features two “Meet the Expert” roundtable breakfast discussions between senior scientists and trainees, a career-oriented workshop, “Towards Independence,” and a trainee-development workshop, “Writing for Biomedical Publications.”

Keynote Lecture

Michel Baudry, PhD, Western University of Health Sciences

Organizers

donita_brady_headshot

Donita Brady, PhD

Associate Professor, University of Pennsylvania

Dar_Arvin-pic

Arvin Dar, PhD

Associate Professor and Associate Director, Icahn School of Medicine at Mount Sinai

missing-person-icon-for-src-web-pics

Jorrit Enserink, PhD

Group Leader, Oslo University Hospital

missing-person-icon-for-src-web-pics

Victoria Sanz-Moreno, PhD

Professor, Barts Cancer Institute

Email Sign Up